Prelude Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$943K Buy
+118,568
New +$943K 0.09% 275
2024
Q3
Sell
-10,867
Closed -$43.5K 1462
2024
Q2
$43.5K Sell
10,867
-9,510
-47% -$38K ﹤0.01% 1058
2024
Q1
$69.5K Buy
+20,377
New +$69.5K ﹤0.01% 1119